Key Insights

Highlights

Treatment Research

1 treatments under study, led by Polyiclc

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

100.0%

1 terminated out of 1 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

1 of 0 completed with results

Key Signals

1 with results0

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Terminated1

Clinical Trials (1)

Research Network

Common Treatments

  • Polyiclc1

Active Sponsors

  • Oncovir, Inc.1
  • Nina Bhardwaj1

Top Investigators

Related Conditions

  • Breast Cancer1
  • Squamous Cell Carcinoma Of The Skin1
  • Squamous Cell Carcinoma Of The Head And Neck1
  • Sarcoma Of The Skin1
  • Melanoma1

Activity Timeline